Monday, 10th October 2016
Sala Dolors Aleu – Edifici Cluster II, Barcelona Science Park
Baldiri Reixac, 4 - 08028 Barcelona
Many scientists follow a career in research without considering alternatives. This course of action often ends up being unsatisfactory, as it leads them to take up unsuitable jobs or to abandon science altogether. This session will provide researchers at any point in their careers with the opportuniy to look beyond the bench and to discover new and exciting career options.
9.15 - 9.30 h – Registration
9.30 - 9.35 h – Welcome by Dr. Ignasi Belda “Associate Director at Parc Científic de Barcelona”
9.35 - 9.45 h – Introduction by Carolina Marí “Head of Human Resources at IBEC”
9.45 - 10.45 h – Speaker introductions
10.45 - 11.00 – General questions
11.00 - 12.00 h – Informal discussion and mid-morning snack
- Joaquim Calbó, PhD - Scientific Project Manager, Centre for Genomic Regulation (CRG)
- Alexia-Ileana Zaromytidou, PhD - Chief Editor, Nature Cell Biology
- Guzmán Sánchez, PhD - Cofounder and scientific director, Scienseed SL
- Andreu Soldevila, CEO, LEANBIO
- Lurdes Jordi, PhD. - Innovation and knowledge transfer director, Fundació Bosch i Gimpera
| ||Joaquim Calbó, PhD - Scientific Project Manager,
Centre for Genomic Regulation (CRG) |
Joaquim obtained his Ph.D. in Biochemistry from the University of Barcelona, followed by 6-year post-doctoral experience at the NKI (Amsterdam, The Netherlands). He moved back to Barcelona as Research Associate at the IRB Barcelona, where he also earned experience as scientific manager. Joaquim complemented his education with a Master Degree of Research Management at the Barcelona School of Management (IDEC-UPF), and joined the International and Scientific Affairs team of the Centre for Genomic Regulation (CRG) as Scientific Project Manager. Currently, Joaquim is responsible for the planning and management of CRG-led coordinated projects and institutional collaborations.
| || |
Alexia-Ileana Zaromytidou, PhD - Chief Editor, Nature Cell Biology
Alexia-Ileana Zaromytidou received her PhD from the London Research Institute of Cancer Research UK in London, UK (now the Francis Crick Institute) in January 2007. Her doctoral work with Richard Treisman centred on the molecular interactions between actin-regulated transcription factors and their coactivators in the context of MAPK and Rho signaling responses. She pursued her postdoctoral research in the lab of Joan Massagué at Memorial Sloan-Kettering Cancer Center in New York, where she studied how different phosphorylation inputs affect TGFβ/BMP pathway activity to achieve distinct biological outcomes. In September 2010 she joined the editorial team of Nature Cell Biology as the editor responsible for the areas of cancer biology, mechanobiology, cell adhesion, migration and the cytoskeleton, and became Chief editor of the journal in November 2015.
| || |
Guzmán Sánchez, PhD - Cofounder and scientific director, Scienseed SL
Guzmán is the co-founder of Scienseed, an agency for the communication of science. Scienseed uses all available online tools to communicate science in the most creative and effective way. At his company they create videos, websites, animations, apps and videogames, publications and press releases as well as performing social media campaigns and public engagement activities. Guzmán holds a PhD in Molecular Biology and he did research for 10 years at institutions like the University of Leeds (UK), Centro de Biología Molecular Severo Ochoa (Spain), University of Montreal (Canada), University of Leicester (UK) and the Max-Planck Institute (Germany). In addition, he was an active collaborator of different online media where he specialized in science dissemination with a particular focus in exploring the science/society interphase.
| || Andreu Soldevila - CEO, LEANBIO |
PhD in Biology,MsC in Biotechnology, MsC in Microbiology and Genètics, MsC in Environmental
sciences, BS in Biology and BS in Biotechnology with 16 years of experience in the biotechnology and biopharmaceutical
industry. I developed as a professional in the area of small molecules, peptides, biotherapeutics
and in the last years specially in New Biological entities and Biosimilars. Professionally, I am interested
in functions related to science and business (research and development, business development, technology transfer, project management) in the biotech and biopharma sectors.
Lurdes Jordi, PhD - Innovation and knowledge transfer director, Fundació Bosch i Gimpera
Fundació Bosch i Gimpera is the Tech Transfer Office of the University of Barcelona.
She joined Fundació Bosch Gimpera in 2006.She is responsible for the strategic management and commercial development of all technologies, and intellectual property (IP) arising from University of Barcelona. This includes the formation of startup companies around University of Barcelona technologies. Her team is also responsible for generating, structuring, and negotiating research alliances and collaborations between University of Barcelona faculty and industry.
Prior to joining FBG she served as regulatory affairs manager at a pharmaceutical company during 9 years and spent three years as a researcher in a chemical company. She holds a PhD in organic chemistry from University of Barcelona and a master’s degree in business administration.